Given the market cap, the upside vs downside play is amazing. Downside is very limited in my book and very blue sky upside.
We have some major re-rating news ahead.... revenue from the UK, deals in other countries, Clinical results.....
They also have the Prostate market ahead, which could be bigger still....
HTX is now firmly in my long term stockpile.
